MSB 2.51% 97.0¢ mesoblast limited

Ann: Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease, page-44

  1. 238 Posts.
    lightbulb Created with Sketch. 7
    yes seems ann timed nicely to give Aussies a heads up. Also the Aus article couple of days ago would Never win a journalism prize but yet pointed straight to Mr Pratt, who we all know has good friend in the USA.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.